New research has indicated that treatment with the targeted therapy drug crizotinib stops the growth of lung tumors that developed due to rearrangements of the ROS1 gene. In an article receiving Online First publication in the iNew England Journal of Medicine/i to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study ...Sunday, 28 September 2014
ROS1-Positive Lung Cancer may Respond to Crizotinib Treatment
New research has indicated that treatment with the targeted therapy drug crizotinib stops the growth of lung tumors that developed due to rearrangements of the ROS1 gene. In an article receiving Online First publication in the iNew England Journal of Medicine/i to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment